Maria J. Redondo

Baylor College of Medicine
Country flagUnited States

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (21)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Background. Elevated serum IgA levels have been observed in various autoimmune conditions, including type 1 diabetes (T1D). However, whether children with T1D and elevated serum IgA have unique features has not been studied. We aimed to evaluate the prevalence and characteristics associated with elevated serum IgA at the onset of pediatric T1D. Materials and Methods. We analyzed demographic, clinical, and laboratory data retrospectively collected from 631 racially diverse children (6 months–18 years of age) with T1D who had serum IgA levels measured within 90 days of T1D diagnosis. Univariable and multivariable logistic regression models were used to identify characteristics that were significantly associated with elevated versus normal IgA. Results. Elevated serum IgA was present in 20.3% (128/631) of the children with newly diagnosed T1D. After adjusting for other variables, A1c level ( p = 0.029 ), positive insulin autoantibodies (IAA) ( p = 0.041 ), negative glutamic acid decarboxylase autoantibodies (GADA) ( p = 0.005 ) and Hispanic ethnicity ( p < 0.001 ) were significantly associated with elevated serum IgA. After adjustment for confounders, the odds of elevated serum IgA were significantly increased with positive IAA (OR 1.653, 95% CI 1.019–2.679), higher HbA1c (OR 1.132, 95% CI 1.014–1.268) and Hispanic ethnicity (OR 3.279, 95% CI 2.003–5.359) but decreased with GADA positivity (OR 0.474, 95% CI 0.281–0.805). Conclusions. Elevated serum IgA is present in 20.3% of the children at T1D onset and is associated with specific demographic and clinical characteristics, suggesting a unique pathogenesis in a subset of individuals. Further studies are warranted to investigate the IgA response, its role in T1D pathogenesis, and whether these associations persist over time.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (8)

Jean W. Hsu

Baylor College of Medicine

UNITED STATES
View details

Sarah Richardson

Associate Professor in Cellular Biomedicine

University of Exeter

UNITED KINGDOM
View details

Todd Brusko

Professor/Scientific Director

University of Florida

UNITED STATES
View details

Åke Lernmark

Lund University

SWEDEN
View details

Xiaofan Huang

Baylor College of Medicine

UNITED STATES
View details

Stephen Rich

Harrison Professor and Founding Director (Emeritus)

University of Virginia

UNITED STATES
View details

Alberto Pugliese

Chair and Professor

Beckman Research Institute, City of Hope

UNITED STATES
View details

Jennifer Posey

Assistant Professor

Baylor College of Medicine

UNITED STATES
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.